(Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 |
Sales | 315,660 | 377,240 | 358,000 | 308,490 | 361,940 |
Sales Growth | -16.32% | +5.37% | +16.05% | -14.77% | +1.07% |
Net Income | -102,450 | -83,770 | -6,330 | -5,830 | 20,950 |
Net Income Growth | -22.30% | -1,223.38% | -8.58% | -127.83% | -59.60% |
Inogen Inc (INGN)
9.83 x 4 9.84 x 6
Post-market by (Cboe BZX)
9.84 -0.07 (-0.71%) 02/24/25 [NASDAQ]
9.83 x 4 9.84 x 6
Post-market 9.84 unch (unch) 16:02 ET
for Mon, Feb 24th, 2025
Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen concentrator solutions for portable and stationary use. Inogen's flagship product, One G4 is a single-solution POC.
Fiscal Year End Date: 12/31